Postoperative mortality was 25,0% in this subgroup of patients.
In 10 patients completion pancreatectomy was not performed during first relaparotomy, including 1 patient after gastrectomy and 4 patients after left pancreas resection. 8 patients (80%) of this group died. Of 2 survived patients from this group in 1 patients there was no recurrent bleeding, and in another patient completion pancreatectomy was done after recurrent bleeding. In all other 8 patients from 1 to 5 recurrent bleedings occurred (mean 2,1 AE 1,4), fatal in 4 patients. Other 4 patients died of septic complications. Mortality in patients without completion pancreatectomy was 88,9%.
Completion pancreatectomy should be done whenever possible in patients with late severe hemorrhage and POPF grade C. In our first experience Laparoscopic pancreaticoduodenectmoy (LPD) was associated with higher morbidity and we restricted our indications to patients at lower risk of pancreatic fistula (PF). Our aim was to analyse the learning curve effect on the outcome. Method: Between April 2011 e September 2017, 100 LPD were performed by pure laparoscopic approach and one layer pancreaticojejunal anastomosis. The demographics, surgical and the outcome data of the last 50 LPD were compared to the first 50 LPD. Results: No difference regarding age (57 vs 60, p = 0.20), female (42% vs 42%) and BMI (24 vs 23, p = 0.39). Less resections for pancreatic adenocarcinoma (22% vs 32%, p [ 0.047) and for ampulloma (14 vs 26, p = 0.26). No difference on the operative time (335 vs 342, p = 0.62) and conversion (8% vs 8%) but Less blood loss (250 vs 368 vs, p [ 0.024) and transfusion (4% vs 12%, p = 0.50). Similar 90 days mortality (4% vs 4%). Less overall morbidity (68% vs 76%, p = 0.37), less grades B and C PF (33% vs 42%, p = 0.33), less bleeding (18% vs 26%, p = 0.47), less re-interventions for severe complications (6 % vs 14%, p [ 0.039), less readmission (4% vs 8%, p = 0.40), less delayed gastric emptying (10% vs 16%, p = 0.37), similar drained collections (4% vs 4%) but more biliary fistula (18% vs 8%, p = 0.137). Hospital stay was shorter (22 vs 28, p [ 0.033). Conclusions: Although in the second period less resection were done for pancreatic adenocarcinoma, at lower risk of PF, the outcome of LPD was better related to patient selection, improved surgical technique and management. With the widespread of laparoscopic pancreatic surgery, enucleation is considered as an excellent indication to the laparoscopic approach. Our aim was to analyze our indications and results. Methods: From January 2008 to September 2017, among the 422 patients who underwent laparoscopic pancreatic resection, 41(10%) underwent laparoscopic enucleations and were studied retrospectively. Results: The mean age was 50 (17-74), mean BMI 25 (19-36) and 29 were females (71%). Main indications were neuroendocrine tumor (26; 63%); Mucinous cystadenoma (7; 17%), other benign cysts (7; 17%) and only one intraductal papillary mucinous neoplasia (IPMN) (3%). Lesions were located in the head (n=14; 34%).The mean size was 24 mm (9-80). The mean operative time was 110 mn (30-330), the mean blood loss was 64 ml (0-800) ml and no transfusion and one conversion. No 90 days mortality. Overall morbidity in 14 patients (34%), represented by pancreatic fistula of grades B and C (5;12%), bleeding (2;5%), one drained collection and no -intervention. Lymph nodes was harvested in 14 patients (34%) with a mean number 0.7(0-5) and negative in all. The mean hospital stay was 11 days (4e42). Conclusion: The excellent outcome of laparoscopic enucleation is explained by the low rate of enucleation for IPMN, which are theoretically at higher risk of complications. IPMN of good indications to the laparoscopic approach (peripheral branch ducts) do not necessary need surgery, and those who need surgery (small revealed by pancreatitis) are not good indications for the laparoscopic approach related to inflammation and difficult location (deep and small). Electronic Posters (EP02A-EP02F) e Pancreas S635
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